Average Co-Inventor Count = 5.93
ph-index = 26
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (26 from 1,149 patents)
2. University of Texas System (14 from 5,444 patents)
3. Hoffmann-la Roche Inc. (11 from 4,942 patents)
4. Madrigal Pharmaceuticals, Inc. (3 from 25 patents)
5. Exactech, Inc. (2 from 76 patents)
6. Via Pharmaceuticals, Inc. (2 from 5 patents)
7. F. Hoffmann-la Roche Ag (168 patents)
58 patents:
1. 12286406 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
2. 11958849 - GLS1 inhibitors for treating disease
3. 11753381 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
4. 11718612 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
5. 11713313 - GLS1 inhibitors for treating disease
6. 11690850 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
7. 11491178 - Chitosan covalently linked with small molecule integrin antagonist for targeted delivery
8. 11370786 - GLS1 inhibitors for treating disease
9. 11173145 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
10. 11084804 - Modulators of ATP-binding cassette transporters
11. 11046649 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
12. 10766892 - GLS1 inhibitors for treating disease
13. 10738043 - GLS1 inhibitors for treating disease
14. 10626111 - Modulators of ATP-binding cassette transporters
15. 10398562 - Talar implant for modifying joint kinematics